Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence …
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence …
AH Diacon, PR Donald, A Pym, M Grobusch… - 2012 - pubmed.ncbi.nlm.nih.gov
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence …
AH Diacon, PR Donald, A Pym… - Antimicrobial …, 2012 - researchinformation.amsterdamumc …
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
[PDF][PDF] Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect …
AH Diacon, PR Donald, A Pym, M Grobusch… - 2012 - researchgate.net
MATERIALS AND METHODS Study population. The study subjects were newly diagnosed
with MDR pulmonary TB due to M. tuberculosis resistant to (at least) both INH and RMP, who …
with MDR pulmonary TB due to M. tuberculosis resistant to (at least) both INH and RMP, who …
[引用][C] Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect …
AH DIACON, PR DONALD, N LOUNIS… - Antimicrobial …, 2012 - pascal-francis.inist.fr
Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant
Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug …
Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug …
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence …
AH Diacon, PR Donald, A Pym, M Grobusch… - Antimicrobial Agents …, 2012 - europepmc.org
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence …
AH Diacon, PR Donald, A Pym… - … , DC, 1972, currens, 2012 - repository.uantwerpen.be
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
[HTML][HTML] Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect …
AH Diacon, PR Donald, A Pym… - Antimicrobial Agents …, 2012 - ncbi.nlm.nih.gov
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: Long-term outcome, tolerability, and effect on emergence …
AH Diacon, PR Donald, A Pym, M Grobusch… - 2012 - scholar.sun.ac.za
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence …
AH Diacon, PR Donald, A Pym, M Grobusch… - 2012 - cabidigitallibrary.org
The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …
multidrug-resistant pulmonary tuberculosis treated with either the new diarylquinoline …